MONOCYCLIC PYRIDINE DERIVATIVE

The present invention discloses a compow1d represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH2-; E represents a nitrogen-contai...

Full description

Saved in:
Bibliographic Details
Main Authors Yusuke NAKATANI, Isao OHASHI, Setsuo FUNASAKA, Keigo TANAKA, Yoshinobu YAMANE, Yuki KAROJI, Satoshi NAGAO, Toshimi OKADA
Format Patent
LanguageEnglish
Published 20.10.2020
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention discloses a compow1d represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH2-; E represents a nitrogen-containing non-aromatic heterocycle; R1 represents an alkoxy group, an alkoxy alkoxy group or the like; R2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R3 represents a hydrogen atom, an alkyl group, an a1koxy group or the like; and R4 represents a C1-6 alkyl group, with the proviso that when E represents an azetidine ring and R2 or R3 is present on a nitrogen atom on the azetidine ring, the R2 or R3 does not represent a hydrogen atom.
Bibliography:Application Number: MY2015PI702696